Navigation Links
3Bar Biologics Secures $2M To Help Farmers Increase Crop Yields with Naturally Occurring Microbes
Date:8/16/2017

Today, 3Bar Biologics Inc., the provider of a beneficial microbe delivery system, announced it has secured $2M in funding from an impressive group of investors, including Rev1 Ventures, Maumee Ventures, Ohio TechAngel Funds, Queen City Angels, Carmen Innovations, and SVG Thrive Fund. With this investment, 3Bar is broadening availability of its groundbreaking offering that uses naturally occurring microbes to help farmers improve the quantity and quality of crop production.

3Bar’s first commercially available product, Bio-YIELD®, is a patented delivery system that leverages living microorganisms to stimulate a plant’s defense, optimizing the chances for greater yield across a broad range of growing conditions.

“Our system provides a natural solution that easily fits in with farmers current planting practices.” said Bruce Caldwell, CEO of 3Bar Biologics. “With this new investment, 3Bar can accelerate the development of new solutions that support a market that is ripe for change.”

Building on over 15 years of research at The Ohio State University, Bio-Yield® uses living microbes that are sourced and discovered in local fields and activated on-site. Farmers simply press a button to activate the microbes, which begin multiplying when they come in contact with the growth solution. When the mixed product is applied to seeds, each drop contains millions of microbes that grow with the plant.

“The possibilities for 3Bar’s technology are limitless,” said Jane Fife, chief science officer at 3Bar. “The use of more effective beneficial microbes is a giant leap forward for the industry, and we believe there are many other potential use cases. We are dedicated to delivering the most viable microbes to farmers worldwide.”

“We made an early investment in 3Bar because we saw the promise of their research-backed offering and their unwavering commitment to providing farmers with a solution that works,” said Dave Bergeron, SVP Venture Development at Rev1 Ventures.

On average, Bio-YIELD® delivers a five times return on investment for farmers. To learn more, visit http://www.3barbiologics.com, and check them out at September’s Ag Innovation Showcase in St. Louis, MO.

About 3Bar Biologics
3Bar Biologics is committed to helping farmers improve the quantity and quality of crop production with its beneficial microbe delivery system. Born out of extensive research at The Ohio State University, 3Bar’s patented system uses naturally occurring microbes discovered from local fields and activated on-site to more effectively stimulate plant defenses and increase crop yield. 3Bar is driving profitability for farmers and their suppliers by easily integrating with existing practices and reducing the industry’s dependence on synthetic chemicals. For more information, visit http://www.3barbiologics.com.

###

Read the full story at http://www.prweb.com/releases/2017/08/prweb14600238.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. As the life science industry evolves, it is clear that biologics are here to stay!
2. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
3. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
4. Predictive Biomarker Discovery for Oncology Small-Molecules and Biologics - a Webinar Hosted by Xtalks
5. Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
6. Synthetic Biologics to Present at OneMedForum New York 2013
7. Synthetic Biologics Initiates Manufacturing Process for C. difficile Infectious Disease Program
8. Synthetic Biologics to Report Second Quarter 2013 Financial Results
9. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
10. BiologicsMD, Inc. Announces Issuance of First U.S. Patent for PTH-CBD™
11. Freeslate’s Biologics Formulation System Selected by Sanofi Pasteur to Improve Efficiency of Formulation Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... optimization firm for the life sciences and healthcare industries, announces a presentation by ... Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/28/2017)... 2017 The report "Video Surveillance ... Servers, Storage Devices), Software (Video Analytics, VMS), and Service ... Forecast to 2022", published by MarketsandMarkets, the market was ... projected to reach USD 75.64 Billion by 2022, at ... base year considered for the study is 2016 and ...
Breaking Biology News(10 mins):